These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30734242)

  • 1. Use of FDA's Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine Exposure.
    Eworuke E; Welch EC; Tobenkin A; Maro JC
    Drug Saf; 2019 Jul; 42(7):897-906. PubMed ID: 30734242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
    Kesselheim AS; Bykov K; Gagne JJ; Wang SV; Choudhry NK
    Neurology; 2016 Oct; 87(17):1796-1801. PubMed ID: 27683844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
    Hansen RN; Nguyen HP; Sullivan SD
    Epilepsy Res; 2013 Sep; 106(1-2):237-43. PubMed ID: 23726541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis.
    De Vecchis R; Ariano C; Giasi A; Cioppa C
    Minerva Cardioangiol; 2018 Jun; 66(3):349-359. PubMed ID: 28497941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranolazine overdose-induced seizures.
    Akil N; Bottei E; Kamath S
    Am J Emerg Med; 2015 Dec; 33(12):1843.e5-6. PubMed ID: 26072257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury.
    Schierhout G; Roberts I
    Cochrane Database Syst Rev; 2000; (2):CD000173. PubMed ID: 10796698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute generalized exanthematous pustulosis associated with ranolazine.
    Grelck K; Stewart N; Rosen L; Sukal S
    Cutis; 2015 Oct; 96(4):E18-21. PubMed ID: 26682297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of seizure clusters: A prospective observational study of adult patients with epilepsy.
    Detyniecki K; O'Bryan J; Choezom T; Rak G; Ma C; Zhang S; Bonito J; Hirsch LJ
    Epilepsy Behav; 2018 Nov; 88():349-356. PubMed ID: 30344026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic burden of breakthrough seizures.
    Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranolazine-induced lipid storage myopathy presenting with respiratory failure and head drop.
    Paul P; Vazquez Do Campo R; Liewluck T; Naddaf E
    Neuromuscul Disord; 2021 Jun; 31(6):546-550. PubMed ID: 33903020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database.
    McAfee AT; Holdridge KC; Johannes CB; Hornbuckle K; Walker AM
    Curr Drug Saf; 2008 May; 3(2):123-31. PubMed ID: 18690990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children.
    Rowhani-Rahbar A; Fireman B; Lewis E; Nordin J; Naleway A; Jacobsen SJ; Jackson LA; Tse A; Belongia EA; Hambidge SJ; Weintraub E; Baxter R; Klein NP
    JAMA Pediatr; 2013 Dec; 167(12):1111-7. PubMed ID: 24126936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic drug-drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus.
    Zack J; Berg J; Juan A; Pannacciulli N; Allard M; Gottwald M; Zhang H; Shao Y; Ben-Yehuda O; Jochelson P
    Clin Pharmacol Drug Dev; 2015 Mar; 4(2):121-9. PubMed ID: 27128216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine-Associated Myoclonus.
    Trehan N; Singh M; Kottam AR
    Am J Ther; 2018; 25(4):e507-e508. PubMed ID: 28452847
    [No Abstract]   [Full Text] [Related]  

  • 15. Ranolazine Induced Delirium as a Rare Side Effect.
    Zagelbaum NK; Mondal P; Frishman WH; Yandrapalli S
    Am J Ther; 2018; 25(6):e700-e701. PubMed ID: 30010629
    [No Abstract]   [Full Text] [Related]  

  • 16. Unprovoked seizures after traumatic brain injury: A population-based case-control study.
    Mahler B; Carlsson S; Andersson T; Adelöw C; Ahlbom A; Tomson T
    Epilepsia; 2015 Sep; 56(9):1438-44. PubMed ID: 26332184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis.
    Brigo F; Nardone R; Tezzon F; Trinka E
    Epilepsy Behav; 2015 Aug; 49():325-36. PubMed ID: 25817929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
    Page RL; Ghushchyan V; Read RA; Hartsfield CL; Koch BR; Nair KV
    Am J Cardiol; 2015 Nov; 116(9):1321-8. PubMed ID: 26358510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of renal impairment on multiple-dose pharmacokinetics of extended-release ranolazine.
    Jerling M; Abdallah H
    Clin Pharmacol Ther; 2005 Sep; 78(3):288-97. PubMed ID: 16153399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam in toxic seizures.
    Lee T; Warrick BJ; Sarangarm P; Alunday RL; Bussmann S; Smolinske SC; Seifert SA
    Clin Toxicol (Phila); 2018 Mar; 56(3):175-181. PubMed ID: 28753046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.